Clinical Trial Update: Effect of a Cannabinoid Agonist on Colonic Sensory Functions in Patients With Irritable Bowel Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a cannabinoid agonist's effect on colonic sensory function in patients with Irritable bowel syndrome, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• Cannabinoid agonist

Snippet

Sponsor: Michael Camilleri | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2013-03-13